MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,175,755 | +398.7% | 68,853 | +308.2% | 0.00% | – |
| Q2 2023 | $436,323 | -73.6% | 16,866 | -75.5% | 0.00% | – |
| Q1 2023 | $1,651,303 | +306.2% | 68,747 | +229.8% | 0.00% | – |
| Q4 2022 | $406,517 | -27.9% | 20,847 | -22.3% | 0.00% | – |
| Q3 2022 | $564,000 | +3.7% | 26,841 | -3.9% | 0.00% | – |
| Q2 2022 | $544,000 | -36.7% | 27,943 | -28.4% | 0.00% | – |
| Q1 2022 | $859,000 | -51.5% | 39,007 | -64.9% | 0.00% | – |
| Q4 2021 | $1,772,000 | -20.1% | 111,094 | -0.3% | 0.00% | – |
| Q3 2021 | $2,219,000 | +1132.8% | 111,398 | +970.0% | 0.00% | – |
| Q2 2021 | $180,000 | -32.1% | 10,411 | -22.0% | 0.00% | – |
| Q1 2021 | $265,000 | – | 13,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |